Helen E. Burston

602 total citations
9 papers, 215 citations indexed

About

Helen E. Burston is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Helen E. Burston has authored 9 papers receiving a total of 215 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Cell Biology. Recurrent topics in Helen E. Burston's work include Cellular transport and secretion (3 papers), Fungal and yeast genetics research (3 papers) and Cancer Cells and Metastasis (2 papers). Helen E. Burston is often cited by papers focused on Cellular transport and secretion (3 papers), Fungal and yeast genetics research (3 papers) and Cancer Cells and Metastasis (2 papers). Helen E. Burston collaborates with scholars based in Canada and United States. Helen E. Burston's co-authors include Elizabeth Conibear, Michael Davey, Beverly Wendland, Lymarie Maldonado‐Báez, Ben Montpetit, Robert Rottapel, Kevin R. Brown, Oliver A. Kent, Alastair H. Kyle and Andrew I. Minchinton and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Cell Biology and Clinical Cancer Research.

In The Last Decade

Helen E. Burston

8 papers receiving 208 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Helen E. Burston Canada	7	132	102	32	26	21	9	215
Yaroslav Fedyshyn United States	9	222 1.7×	47 0.5×	16 0.5×	15 0.6×	32 1.5×	12	306
Fazhi Yu China	8	57 0.4×	36 0.4×	30 0.9×	18 0.7×	25 1.2×	13	192
Anna Mascia Italy	10	226 1.7×	79 0.8×	8 0.3×	17 0.7×	28 1.3×	10	341
Akshada Gajbhiye India	8	162 1.2×	25 0.2×	11 0.3×	16 0.6×	35 1.7×	12	244
Thuy Thi Thu Tran United States	6	84 0.6×	61 0.6×	16 0.5×	10 0.4×	7 0.3×	7	181
Stanimir Dulev United States	7	344 2.6×	65 0.6×	8 0.3×	10 0.4×	21 1.0×	9	363
Imre F. Schene Netherlands	7	248 1.9×	21 0.2×	26 0.8×	19 0.7×	23 1.1×	9	313
Jimmy J.L.L. Akkermans Netherlands	7	121 0.9×	82 0.8×	16 0.5×	6 0.2×	21 1.0×	13	206
Logesvaran Krshnan United Kingdom	7	220 1.7×	130 1.3×	23 0.7×	11 0.4×	34 1.6×	8	333
Jan Kosla Czechia	9	107 0.8×	26 0.3×	13 0.4×	19 0.7×	30 1.4×	13	175

Countries citing papers authored by Helen E. Burston

Since Specialization

Citations

This map shows the geographic impact of Helen E. Burston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen E. Burston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen E. Burston more than expected).

Fields of papers citing papers by Helen E. Burston

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen E. Burston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen E. Burston. The network helps show where Helen E. Burston may publish in the future.

Co-authorship network of co-authors of Helen E. Burston

This figure shows the co-authorship network connecting the top 25 collaborators of Helen E. Burston. A scholar is included among the top collaborators of Helen E. Burston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen E. Burston. Helen E. Burston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Hyer, Marc L., David A. Gallo, Vivek Bhaskaran, et al.. (2023). Abstract C163: KRAS alterations combined with TP53 mutations as novel synthetic lethal genomic lesions for PKMYT1 inhibition. Molecular Cancer Therapeutics. 22(12_Supplement). C163–C163. 2 indexed citations

Burston, Helen E., Oliver A. Kent, Laudine Communal, et al.. (2021). Inhibition of relaxin autocrine signaling confers therapeutic vulnerability in ovarian cancer. Journal of Clinical Investigation. 131(7). 20 indexed citations

Burston, Helen E., et al.. (2018). Abstract IA27: Functional genetic architecture of serous ovarian cancer. Clinical Cancer Research. 24(15_Supplement). IA27–IA27.

Kent, Oliver A., María José Sandí, Helen E. Burston, Kevin R. Brown, & Robert Rottapel. (2016). An oncogenic KRAS transcription program activates the RHOGEF ARHGEF2 to mediate transformed phenotypes in pancreatic cancer. Oncotarget. 8(3). 4484–4500. 18 indexed citations

Burston, Helen E., Björn D. M. Bean, Lymarie Maldonado‐Báez, et al.. (2015). The alternate AP-1 adaptor subunit Apm2 interacts with the Mil1 regulatory protein and confers differential cargo sorting. Molecular Biology of the Cell. 27(3). 588–598. 10 indexed citations

Burston, Helen E., Lymarie Maldonado‐Báez, Michael Davey, et al.. (2009). Regulators of yeast endocytosis identified by systematic quantitative analysis. The Journal of Cell Biology. 185(6). 1097–1110. 92 indexed citations

Burston, Helen E., Michael Davey, & Elizabeth Conibear. (2008). Genome-Wide Analysis of Membrane Transport Using Yeast Knockout Arrays. Methods in molecular biology. 457. 29–39. 9 indexed citations

Robichaud, Annette, Stephanie A. Tuck, Stacia Kargman, et al.. (2005). Gob-5 Is Not Essential for Mucus Overproduction in Preclinical Murine Models of Allergic Asthma. American Journal of Respiratory Cell and Molecular Biology. 33(3). 303–314. 43 indexed citations

Kyle, Alastair H., Lynsey A. Huxham, Jennifer H.E. Baker, Helen E. Burston, & Andrew I. Minchinton. (2003). Tumor distribution of bromodeoxyuridine-labeled cells is strongly dose dependent.. PubMed. 63(18). 5707–11. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact